Breast Ultrasonography and Polycystic Ovary Syndrome

• Sponsor: Kanuni Sultan Suleyman Training and Research Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT04231786
• Collaborator: (none)
• Enrollment: 1
• Location: 1
• Actual Duration (Months): 6
• Patients Per Site Per Month: 0.2

Study Details

Study Description

Brief Summary

The results of the evaluation of breast ultrasonography results of patients with polycystic ovary syndrome diagnosis over 30 years of age will be evaluated.

Patients admitted to the outpatient clinic and rotterdam criteria according to laboratory data and polycystic ovary syndrome patients diagnosed by the same radiologist the next day after the end of menstrual breast ultrasonography. The aim of this study is to show the association of polycystic ovary syndrome and fibrocystic breast.

Condition or Disease	Intervention/Treatment	Phase
Breast Diseases; Polycystic Ovary	Procedure: Breast ultrasonography findings

Study Design

• Study Type: Observational [Patient Registry]
• Actual Enrollment: 1 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Breast Ultrasonography Findings in Patients Over 30 Years With Polycystic Ovary Syndrome
• Actual Study Start Date: Jan 14, 2020
• Actual Primary Completion Date: Jul 14, 2020
• Actual Study Completion Date: Jul 14, 2020

Outcome Measures

Primary Outcome Measures

1. Breast ultrasonography findings [1 month]

   Breast ultrasonography findings in patients over 30 years of age diagnosed with polycystic ovary syndrome. THE PRESENCE OF FIBROCISTIC DISEASE WILL BE EVALUATED FOR FIBROADENOMA OR OTHER BREAST DISEASE. YES OR NO ; WILL BE REGISTERED.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 30 Years to 45 Years
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Over 30 years

• diagnosed with polycystic ovary syndrome according to rotterdam criteria

• no previous history of breast disease

• female patients

Exclusion Criteria:

• Under 30 years

• polycystic ovary syndrome

• patients with a previously known history of breast disease

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Kanuni Sultan Süleyman Training and Research Hospital	Istanbul		Turkey	33404

Sponsors and Collaborators

• Kanuni Sultan Suleyman Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Pınar Kadirogulları, Pınar Kadiroğulları M.D, Department of Obstetrics and Gynecology,Principal Investigator, Kanuni Sultan Suleyman Training and Research Hospital
• ClinicalTrials.gov Identifier: NCT04231786
• Other Study ID Numbers: 2019.05.122
• First Posted: Jan 18, 2020
• Last Update Posted: Sep 3, 2020
• Last Verified: Sep 1, 2020

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Pınar Kadirogulları, Pınar Kadiroğulları M.D, Department of Obstetrics and Gynecology,Principal Investigator, Kanuni Sultan Suleyman Training and Research Hospital: breast diseases; fibrocystic breast; polycystic ovari syndrome; fibroadenoma
• Additional relevant MeSH terms: Polycystic Ovary Syndrome; Breast Diseases

Study Results

No Results Posted as of Sep 3, 2020